Reuters:Â Â China celebrated 60 years of communist rule as a capitalist economy. Reuters:Â Â The IMF cut global debt write-offs to $3.4 trillion. Reuters:Â Â CIT (CIT) is close to a deal to give…
Reuters:  Solvay sold its drug unit to Abbott (ABT) foe $6.6 billion. Reuters:  Kraft (KFT) will launch a hostile bid for Cadbury. Reuters:  The World Bank said not to take the dollar’s…
Reuters:Â Â Obama is trying to push Wall St. reform. Reuters:Â Â German aid for Opel will go in part to Russia for operations there. Reuters:Â Â A global poll shows support for stimulus packages.…
Several consulting firms post annual figures for the world’s most valuable brands. The two best known are probably the Interbrand and BrandZ surveys. They are notably different, up until now at least.…
Now that we are out of the woods in the crash scenario, assuming this week is no ill omen, investors may want to know which of the big companies would start to…
Wasn’t it just last week that we were up eight days in a row on the DJIA? And now we have a sell-the-news reaction to the recent growth numbers. Maybe it is…
Reuters:Â Â UBS (UBS) shares may fall when the Swiss government sells out. Reuters:Â Â The US deficit estimate was trimmed to $1.59 trillion. Reuters:Â Â A homeowner sued Wells Fargo (WFC) over a credit…
Berkshire Hathaway Inc. (NYSE: BRK-A)(BRK-B) has released its Q2-2009 public equity holdings as of June 30, 2009. There are some portfolio changes that have been seen here from the end of Q1…
Bristol Myers Inc. (NYSE: BMY) plans to spend $2.4 billion to buy partner Medarex Inc. (Nasdaq: MEDX). It will get a great deal beyond the cancer monoclonal antibody that developed together. The Medarex…
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market. With help…
Reuters:Â Â The US may give CIT (CIT) short term loans. Reuters:Â Â Intel (INTC) issued a positive forecast and indicated that the PC market may be improving. Reuters:Â Â The US CPI was up…
DJIA component Johnson & Johnson (NYSE: JNJ) has come out with earnings slightly ahead of estimates. The medical and consumer products giant posted $1.15 EPS vs $1.11 estimates and revenues were down…
Douglas A. McIntyre Reuters:  Smart investors are starting to cherry- pick stocks. Reuters:  California may agree on a budget to stop using IOUs. Reuters:  Some stock funds are still making up for lost ground. Reuters:  The…
Reuters:  Cybercrime is spreading fast on Facebook. Reuters:  GM will seek to sell most of its assets to a new company. Reuters:   Madoff got 150 years in prison. Reuters:  AIG (AIG) shareholders will…
Underscoring just how much big pharma will depend on biotech acquisitions for future revenue, an analysis published by Evaluate Pharma today suggests half of the top 100 drugs worldwide by 2014 –…
